J Incl Phenom Macrocycl Chem (2013) 75:211–221
213
(40–100 °C) for 1–6 h, according the classical synthetic
scheme [97–99]. To the reaction mixtures were added
10 ml CH3COOH. The obtained dark colored powders
were filtered off and recrystallized from methanol. Yields
of (1)–(19) are within 90–95 %. The modeled heterocyclic
structural fragments in (13)–(19) structural fragment was
obtained according [100, 101], by mixing of the equimolar
amounts of the starting compounds in 50 ml methanol,
under stirring at heating reflux (50 °C) for 2 h.
methyl]-2,6-dimethoxy-phenol (7): Found, C, 69.50, H,
7.35, N, 8.55; Calc. [C19H24N2O3], C, 69.49, H, 7.37, N,
1
8.53 %; H-NMR: 3.33 (3H, –NCH2, t), 3.31 (3H, –NCH2,
t), 4.11, 4.15 (29 OCH3, s), 5.04 (1H, s), 7.12–7.55 ppm
(6H, m), 11.3 (OH, s, broad), 13C-NMR: 27.8, 28.5 (NCH2),
32.5, 32.4 (29 CH3) 75.1 (NCH), 86.4, 86.7 (–OCH3),
130.0–144.0 ppm (CHAr); 4-methyl-2-[(4-morpholin-4-yl-
benzylidene)-amino]-benzoic acid (8): Found, C, 70.33; H,
6.20; N, 8.66; Calc. [C19H20N2O3], C, 70.35, H, 6.21, N,
1
(4-Dimethylamine-benzylidene)-pyridin-4-yl-amine (1):
Found, C, 74.58; H, 6.70; N, 18.66; Calc. [C14H15N3], C,
74.64; H, 6.71; N, 18.65 %; 1H-NMR: 3.24 (3H, –NCH3, s),
3.27 (3H, –NCH3, s), 5.00 (1H, s), 7.26–7.88 ppm (8H, m),
8.64; H-NMR: 2.25 (3H, –CH3, s), 3.30 (2H, –NCH2, t),
3.32 (2H, –NCH2, t), 4.12 (2H, –NCH2CH2, t), 4.12 (2H,
–NCH2CH2, t), 5.11 (1H, s), 7.22–7.76 (7H, m), 8.45 ppm
(OH, s, broad), 13C-NMR: 27.3, 28.1, 29.30, 29.45
(NCH2CH2), 77.0 (NCH), 126.0–135.5 (CHAr), 177.7 ppm
13C-NMR:
27.8,
28.8
(NCH3),
77.6
(NCH),
127.8–135.8 ppm (CHAr); (4-diethylamine-benzylidene)-
pyridin-4-yl-amine (2): Found, C, 75.88, H; 7.52; N,
16.59 %; Calc. [C16H19N3], C, 75.86; H, 7.56; N, 16.59 %;
1H-NMR: 3.22 (3H, –NCH2, t), 3.29 (3H, –NCH2, t), 3.33,
3.41 (29 CH2, q, J = 7.0 Hz), 5.02 (1H, s), 7.22–7.90 ppm
(8H, m), 13C-NMR: 27.7, 28.2 (NCH3), 32.7, 32.2 (29
CH2) 77.0 (NCH), 128.1–136.6 ppm (CHAr); N,N-diethyl-
N0-(4-pyrrolidin-1-yl-benzylidene)-benzene-1,4-diamine
(3): Found, C, 78.55; H, 8.47; N, 13.07 %; Calc.
(COOH);
amino]-benzoic acid (9): Found, C, 74.10; H, 6.55; N, 9.10;
4-methyl-2-[(4-pyrrolidin-4-yl-benzylidene)-
1
Calc. [C19H20N2O2], C, 74.00, H, 6.54, N, 9.08; H-NMR:
2.26 (3H, –CH3, s), 3.32 (2H, –NCH2, t), 3.34 (2H, –NCH2,
t), 3.21 (2H, –NCH2CH2, t), 3.12 (2H, –NCH2CH2, t), 5.06
(1H, s), 7.20–7.88 (7H, m), 8.59 ppm (OH, s, broad), 13C-
NMR: 28.1, 29.5, 29.7, 29.9 (NCH2CH2), 79.0 (NCH),
125.1–133.7 (CHAr), 180.1 ppm (COOH); 4-[(4-hydroxy-
benzylidene)-amino]-benzene-1,3-diol (10): Found, C,
68.10; H, 4.85; N, 6.15; Calc. [C13H11O3N], C, 68.11; H,
4.84; N, 6.11 %; 4-[(3,4-dihydroxy-benzylidene)-amino]-
benzene-1,3-diol (11): Found, C, 59.75; H, 5.00; N, 6.34 %;
Calc. [C13H11O4N], C, 59.73; H, 5.01; N, 6.33 %; 1H-NMR:
5.30 (1H, s), 7.80–7.95 (6H, m), 10.4, 8.59, 8.20, 8.18 ppm
(49 OH, s, broads), 13C-NMR: 81.5 (NCH), 136.8–
140.5 ppm (CHAr), 4-[(3,5-dimethoxy-4-hydroxy-benzyli-
dene)-amino]-benzene-1,3-diol (12): Found, C, 62.30, H,
5.23, N, 4.84; Calc. [C15H15O5N], C, 62.28, H, 5.23, N,
4.84 %; 1H-NMR: 4.46, 4.50 (3H, –OCH3, s), 5.22 (1H, s),
7.56–7.90 (5H, m), 10.4, 8.59, 8.18 ppm (39 OH, s,
broads), 13C-NMR: 33.3, 34.2 (OCH3), 80.0 (NCH),
135.7–139.2 ppm (CHAr). The quinoide forms of (10)–(12),
were obtained by mixing of corresponding compounds
(10)–(12), by mixing of the preliminary dissolved sub-
stances in 25 ml methanol and adding the the equimolar
amount of KOH dissolved in same solvent. 3-Hydroxy-4-
(4-oxo-cyclohexa-2,5-dienylidenemethylimino)-cyclohexa-
2,5-dienone (10a): Found, C, 68.77, H, 3.99, N, 6.15 %,;
Calc. [C13H10O3N], C, 68.10; H, 4.82; N, 6.10 %; 4-[(2-
hydroxy-4-oxo-cyclohexa-2,5-dienylideneamino)-methy-
lene]-2-hydroxy-cyclohexa-2,5-dienone (11a): Found, C,
64.20; H, 3.75, N, 5.77; Calc. [C13H10O4N], C, 59.72; H,
5.00; N, 6.32 %; 4-[(2-hydroxy-4-oxo-cyclohexa-2,5-di-
enylideneamino)-methylene]-2,6-dimethoxy-cyclohexa-
2,5-dienone (12a): Found, C, 62.75, H; 4.55; N, 4.90 %,
Calc. [C15H14O5N], C, 62.22, H, 5.22, N, 4.83 %; 3-amino-
5-phenyl-7-[(4-pyrrolidin-1-yl-benzylidene)-amino]-5,8-
dihydro-[1, 2, 4]triazolo[4,3-a]pyrimidine-6-carbonitrile
(13): Found, C, 67.22, H, 5.66, N, 27.25 %; Calc.
1
[C21H27N3], C, 78.46, H, 8.47; N, 13.07 %; H-NMR: 3.21
(3H, –NCH3, t), 3.30 (3H, –NCH3, t), 3.21, 3.40 (29 CH2,
q, J = 7.1 Hz), 3.12, 3.16 (8H, t, m, J = 6.2 Hz), 5.01
(1H, s), 7.20–7.85 ppm (8H, m), 13C-NMR: 27.2, 28.0
(NCH3), 32.5, 32.1 (29 CH2), 29.7, 28.9, 30.1, 34.4 (49
CH2), 77.2 (NCH), 128.0–135.0 ppm (CHAr); N,N-Die-
thyl-N0-(4-morpholin-1-yl-benzylidene)-benzene-1,4-dia-
mine (4): Found, C, 74.77; H, 8.10; N, 12.55; Calc.
[C21H27N3O], C, 74.74; H, 8.06; N, 12.45 %; 1H-NMR:
3.20 (3H, –NCH3, t), 3.28 (3H, –NCH3, t), 3.20, 3.42 (29
CH2, q, J = 7.1 Hz), 4.22, 4.19 (8H, t, m, J = 7.7 Hz),
5.00 (1H, s), 7.25–7.66 ppm (8H, m), 13C-NMR: 27.3, 28.2
(NCH3), 32.2, 32.0 (29 CH2), 30.2, 30.8, 38.3, 39.1 (49
CH2), 77.0 (NCH), 128.0–136.2 ppm (CHAr); N,N-diethyl-
N0-(4-piperidin-1-yl-benzylidene)-benzene-1,4-diamine
(5): Found, C, 57.11; H, 6.50; N, 9.10; Calc. [C22H30N3I],
1
C, 57.02; H, 6.52; N, 9.07 %; H-NMR: 3.22 (3H, –NCH3,
t), 3.30 (3H, –NCH3, t), 3.29, 3.40 (29 CH2, q,
J = 7.0 Hz), 4.30, 4.20, 4.88 (10H, t, m, m, J = 7.2-
8.3 Hz), 4.77 (1H, m), 5.02 (1H, s), 7.30–7.70 ppm (8H,
m), 13C-NMR: 27.2, 28.1 (NCH3), 30.6 (CH), 32.0, 32.2
(29 CH2), 29.7, 30.2, 30.2, 33.1, 34.1 (59 CH2), 77.3
(NCH), 128.2–135.7 ppm (CHAr); 2-[(4-dimethylamino-
benzylidene)-amino]-4-methyl-benzoic acid (6): Found, C,
72.11, H, 6.62, N, 9.90 %; Calc. [C17H18N2O2], C, 72.33; H,
1
6.44; N, 9.92 %; %; H-NMR: 2.23 (3H, –CH3, s), 3.25
(3H, –NCH3, s), 3.30 (3H, –NCH3, s), 5.11 (1H, s),
7.30–7.90 (7H, m), 9.88 ppm (OH, s, broad), 13C-NMR:
27.0, 28.2 (NCH3), 77.1 (NCH), 125.5–134.4 (CHAr),
178.2 ppm (COOH); 4-[(4-diethylamino-phenylimino)-
123